US 12,128,030 B2
Pharmaceutical composition comprising antiplatelet agent and gastric acid secretion inhibitor
Tae Keun Cho, Incheon (KR); Young Dae Cho, Gyeonggi-do (KR); Eunji Kwon, Seoul (KR); and Myung Jin Shin, Seoul (KR)
Assigned to HK INNO.N CORPORATION, Chungcheongbuk-do (KR)
Appl. No. 17/271,279
Filed by HK INNO.N CORPORATION, Seoul (KR)
PCT Filed Aug. 27, 2019, PCT No. PCT/KR2019/010891
§ 371(c)(1), (2) Date Feb. 25, 2021,
PCT Pub. No. WO2020/045940, PCT Pub. Date Mar. 5, 2020.
Claims priority of application No. 10-2018-0101047 (KR), filed on Aug. 28, 2018.
Prior Publication US 2021/0251967 A1, Aug. 19, 2021
Int. Cl. A61K 31/4184 (2006.01); A61K 9/20 (2006.01); A61K 9/24 (2006.01); A61K 9/48 (2006.01); A61K 31/4365 (2006.01)
CPC A61K 31/4184 (2013.01) [A61K 9/2077 (2013.01); A61K 9/209 (2013.01); A61K 9/4866 (2013.01); A61K 31/4365 (2013.01)] 19 Claims
OG exemplary drawing
 
1. A pharmaceutical composition comprising clopidogrel or a pharmaceutically acceptable salt thereof, and a compound of Formula 1 or a pharmaceutically acceptable salt thereof,

OG Complex Work Unit Chemistry